世界のナノ医薬品市場:成長動向・競争分析2020-2026

【英語タイトル】Global Nanopharmaceuticals Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP01564)・商品コード:QYR20AP01564
・発行会社(調査会社):QYResearch
・発行日:2020年3月20日(※2024年版があります。お問い合わせください)
・ページ数:144
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、ナノ医薬品の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、ナノ医薬品のグローバル市場動向、メーカー別競争状況、種類別市場規模(リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルジョンおよびナノエマルジョン、ナノ懸濁液)、用途別市場規模(がん&腫瘍、自己免疫疾患、炎症、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・ナノ医薬品の種類別市場2015-2026:リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルジョンおよびナノエマルジョン、ナノ懸濁液
・ナノ医薬品の用途別市場2015-2026:がん&腫瘍、自己免疫疾患、炎症、その他
・ナノ医薬品の北米市場分析
・ナノ医薬品のアジア市場分析
・ナノ医薬品の中南米市場分析
・ナノ医薬品の中東・アフリカ市場分析
・関連企業情報:Merck、Pfizer、Novartis、Abbott、GlaxoSmithKline、Roche、Sanofi、Eli Lilly、Astrazeneca、Johnson & Johnson、Celgene、Novavax、Stryker、Gilead Sciences、OSI Pharmaceuticals、Kadmon Pharmaceuticals、Samyang Biopharm、Mitsubishi Pharma、Kaken Pharmaceutical、Selecta Biosciences、Par Pharmaceutical、Cerulean Pharma、Navidea Biopharmaceuticals、Lummy
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.
There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.
In 2019, the global Nanopharmaceuticals market size was US$ 24020 million and is forecast to US$ 57040 million in 2026, growing at a CAGR of 13.0% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Nanopharmaceuticals.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Nanopharmaceuticals market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Nanopharmaceuticals market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Nanopharmaceuticals market. Readers of the report can become informed about current and future trends of the global Nanopharmaceuticals market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Nanopharmaceuticals markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Nanopharmaceuticals market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Nanopharmaceuticals market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Nanopharmaceuticals market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Nanopharmaceuticals market is segmented into
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion
Nanosuspension

Market Segment by Application, the Nanopharmaceuticals market is segmented into
Cancer and Tumor
Autoimmune Disorders
Inflammation
Others

This report includes the following manufacturers; we can also add the other companies as you want.
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy

The study objectives are:
To analyze and research the global Nanopharmaceuticals status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Nanopharmaceuticals manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Nanopharmaceuticals are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Nanopharmaceuticals Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Nanopharmaceuticals Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Liposomes
1.3.3 Polymeric Micelles
1.3.4 Solid Lipid Nanoparticles
1.3.5 Microemulsion and Nnanoemulsion
1.3.6 Nanosuspension
1.4 Market Segment by Application
1.4.1 Global Nanopharmaceuticals Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Cancer and Tumor
1.4.3 Autoimmune Disorders
1.4.4 Inflammation
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Nanopharmaceuticals Revenue (2015-2026)
2.1.1 Global Nanopharmaceuticals Revenue (2015-2026)
2.1.2 Global Nanopharmaceuticals Sales (2015-2026)
2.2 Nanopharmaceuticals Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Nanopharmaceuticals Sales by Regions (2015-2020)
2.2.2 Global Nanopharmaceuticals Revenue by Regions (2015-2020)
2.3 Global Top Nanopharmaceuticals Regions (Countries) Ranking by Market Size
2.4 Nanopharmaceuticals Industry Trends
2.4.1 Nanopharmaceuticals Market Top Trends
2.4.2 Market Drivers
2.4.3 Nanopharmaceuticals Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Nanopharmaceuticals Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Nanopharmaceuticals Manufacturers by Sales (2015-2020)
3.1.1 Global Nanopharmaceuticals Sales by Manufacturers (2015-2020)
3.1.2 Global Nanopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Nanopharmaceuticals Sales in 2019
3.2 Global Top Manufacturers Nanopharmaceuticals by Revenue
3.2.1 Global Nanopharmaceuticals Revenue by Manufacturers (2015-2020)
3.2.2 Global Nanopharmaceuticals Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nanopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanopharmaceuticals as of 2019)
3.4 Global Nanopharmaceuticals Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Nanopharmaceuticals Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Nanopharmaceuticals Market
3.7 Key Manufacturers Nanopharmaceuticals Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Nanopharmaceuticals Historic Market Review by Type (2015-2020)
4.1.2 Global Nanopharmaceuticals Sales Market Share by Type (2015-2020)
4.1.3 Global Nanopharmaceuticals Revenue Market Share by Type (2015-2020)
4.1.4 Nanopharmaceuticals Price by Type (2015-2020)
4.1 Global Nanopharmaceuticals Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Nanopharmaceuticals Sales Forecast by Type (2021-2026)
4.2.3 Global Nanopharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.4 Nanopharmaceuticals Price Forecast by Type (2021-2026)

5 Global Nanopharmaceuticals Market Size by Application
5.1 Global Nanopharmaceuticals Historic Market Review by Application (2015-2020)
5.1.2 Global Nanopharmaceuticals Sales Market Share by Application (2015-2020)
5.1.3 Global Nanopharmaceuticals Revenue Market Share by Application (2015-2020)
5.1.4 Nanopharmaceuticals Price by Application (2015-2020)
5.2 Global Nanopharmaceuticals Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Nanopharmaceuticals Sales Forecast by Application (2021-2026)
5.2.3 Global Nanopharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.4 Nanopharmaceuticals Price Forecast by Application (2021-2026)

6 North America
6.1 North America Nanopharmaceuticals Breakdown Data by Company
6.2 North America Nanopharmaceuticals Breakdown Data by Type
6.3 North America Nanopharmaceuticals Breakdown Data by Application
6.4 North America Nanopharmaceuticals Breakdown Data by Countries
6.4.1 North America Nanopharmaceuticals Sales by Countries
6.4.2 North America Nanopharmaceuticals Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Nanopharmaceuticals Breakdown Data by Company
7.2 Europe Nanopharmaceuticals Breakdown Data by Type
7.3 Europe Nanopharmaceuticals Breakdown Data by Application
7.4 Europe Nanopharmaceuticals Breakdown Data by Countries
7.4.1 Europe Nanopharmaceuticals Sales by Countries
7.4.2 Europe Nanopharmaceuticals Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Nanopharmaceuticals Breakdown Data by Company
8.2 Asia Pacific Nanopharmaceuticals Breakdown Data by Type
8.3 Asia Pacific Nanopharmaceuticals Breakdown Data by Application
8.4 Asia Pacific Nanopharmaceuticals Breakdown Data by Regions
8.4.1 Asia Pacific Nanopharmaceuticals Sales by Regions
8.4.2 Asia Pacific Nanopharmaceuticals Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Nanopharmaceuticals Breakdown Data by Company
9.2 Latin America Nanopharmaceuticals Breakdown Data by Type
9.3 Latin America Nanopharmaceuticals Breakdown Data by Application
9.4 Latin America Nanopharmaceuticals Breakdown Data by Countries
9.4.1 Latin America Nanopharmaceuticals Sales by Countries
9.4.2 Latin America Nanopharmaceuticals Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Nanopharmaceuticals Breakdown Data by Type
10.2 Middle East and Africa Nanopharmaceuticals Breakdown Data by Application
10.3 Middle East and Africa Nanopharmaceuticals Breakdown Data by Countries
10.3.1 Middle East and Africa Nanopharmaceuticals Sales by Countries
10.3.2 Middle East and Africa Nanopharmaceuticals Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Merck Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Merck Nanopharmaceuticals Products and Services
11.1.5 Merck SWOT Analysis
11.1.6 Merck Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Pfizer Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Pfizer Nanopharmaceuticals Products and Services
11.2.5 Pfizer SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Novartis Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Novartis Nanopharmaceuticals Products and Services
11.3.5 Novartis SWOT Analysis
11.3.6 Novartis Recent Developments
11.4 Abbott
11.4.1 Abbott Corporation Information
11.4.2 Abbott Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Abbott Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Abbott Nanopharmaceuticals Products and Services
11.4.5 Abbott SWOT Analysis
11.4.6 Abbott Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Business Overview and Total Revenue (2019 VS 2018)
11.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 GlaxoSmithKline Nanopharmaceuticals Products and Services
11.5.5 GlaxoSmithKline SWOT Analysis
11.5.6 GlaxoSmithKline Recent Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Roche Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Roche Nanopharmaceuticals Products and Services
11.6.5 Roche SWOT Analysis
11.6.6 Roche Recent Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Sanofi Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Sanofi Nanopharmaceuticals Products and Services
11.7.5 Sanofi SWOT Analysis
11.7.6 Sanofi Recent Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Corporation Information
11.8.2 Eli Lilly Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Eli Lilly Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Eli Lilly Nanopharmaceuticals Products and Services
11.8.5 Eli Lilly SWOT Analysis
11.8.6 Eli Lilly Recent Developments
11.9 Astrazeneca
11.9.1 Astrazeneca Corporation Information
11.9.2 Astrazeneca Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Astrazeneca Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Astrazeneca Nanopharmaceuticals Products and Services
11.9.5 Astrazeneca SWOT Analysis
11.9.6 Astrazeneca Recent Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Corporation Information
11.10.2 Johnson & Johnson Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Johnson & Johnson Nanopharmaceuticals Products and Services
11.10.5 Johnson & Johnson SWOT Analysis
11.10.6 Johnson & Johnson Recent Developments
11.11 Celgene
11.11.1 Celgene Corporation Information
11.11.2 Celgene Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Celgene Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Celgene Nanopharmaceuticals Products and Services
11.11.5 Celgene SWOT Analysis
11.11.6 Celgene Recent Developments
11.12 Novavax
11.12.1 Novavax Corporation Information
11.12.2 Novavax Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Novavax Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Novavax Nanopharmaceuticals Products and Services
11.12.5 Novavax SWOT Analysis
11.12.6 Novavax Recent Developments
11.13 Stryker
11.13.1 Stryker Corporation Information
11.13.2 Stryker Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Stryker Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Stryker Nanopharmaceuticals Products and Services
11.13.5 Stryker SWOT Analysis
11.13.6 Stryker Recent Developments
11.14 Gilead Sciences
11.14.1 Gilead Sciences Corporation Information
11.14.2 Gilead Sciences Business Overview and Total Revenue (2019 VS 2018)
11.14.3 Gilead Sciences Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.14.4 Gilead Sciences Nanopharmaceuticals Products and Services
11.14.5 Gilead Sciences SWOT Analysis
11.14.6 Gilead Sciences Recent Developments
11.15 OSI Pharmaceuticals
11.15.1 OSI Pharmaceuticals Corporation Information
11.15.2 OSI Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.15.3 OSI Pharmaceuticals Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.15.4 OSI Pharmaceuticals Nanopharmaceuticals Products and Services
11.15.5 OSI Pharmaceuticals SWOT Analysis
11.15.6 OSI Pharmaceuticals Recent Developments
11.16 Kadmon Pharmaceuticals
11.16.1 Kadmon Pharmaceuticals Corporation Information
11.16.2 Kadmon Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.16.4 Kadmon Pharmaceuticals Nanopharmaceuticals Products and Services
11.16.5 Kadmon Pharmaceuticals SWOT Analysis
11.16.6 Kadmon Pharmaceuticals Recent Developments
11.17 Samyang Biopharm
11.17.1 Samyang Biopharm Corporation Information
11.17.2 Samyang Biopharm Business Overview and Total Revenue (2019 VS 2018)
11.17.3 Samyang Biopharm Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.17.4 Samyang Biopharm Nanopharmaceuticals Products and Services
11.17.5 Samyang Biopharm SWOT Analysis
11.17.6 Samyang Biopharm Recent Developments
11.18 Mitsubishi Pharma
11.18.1 Mitsubishi Pharma Corporation Information
11.18.2 Mitsubishi Pharma Business Overview and Total Revenue (2019 VS 2018)
11.18.3 Mitsubishi Pharma Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.18.4 Mitsubishi Pharma Nanopharmaceuticals Products and Services
11.18.5 Mitsubishi Pharma SWOT Analysis
11.18.6 Mitsubishi Pharma Recent Developments
11.19 Kaken Pharmaceutical
11.19.1 Kaken Pharmaceutical Corporation Information
11.19.2 Kaken Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.19.3 Kaken Pharmaceutical Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.19.4 Kaken Pharmaceutical Nanopharmaceuticals Products and Services
11.19.5 Kaken Pharmaceutical SWOT Analysis
11.19.6 Kaken Pharmaceutical Recent Developments
11.20 Selecta Biosciences
11.20.1 Selecta Biosciences Corporation Information
11.20.2 Selecta Biosciences Business Overview and Total Revenue (2019 VS 2018)
11.20.3 Selecta Biosciences Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.20.4 Selecta Biosciences Nanopharmaceuticals Products and Services
11.20.5 Selecta Biosciences SWOT Analysis
11.20.6 Selecta Biosciences Recent Developments
11.21 Par Pharmaceutical
11.21.1 Par Pharmaceutical Corporation Information
11.21.2 Par Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.21.3 Par Pharmaceutical Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.21.4 Par Pharmaceutical Nanopharmaceuticals Products and Services
11.21.5 Par Pharmaceutical SWOT Analysis
11.21.6 Par Pharmaceutical Recent Developments
11.22 Cerulean Pharma
11.22.1 Cerulean Pharma Corporation Information
11.22.2 Cerulean Pharma Business Overview and Total Revenue (2019 VS 2018)
11.22.3 Cerulean Pharma Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.22.4 Cerulean Pharma Nanopharmaceuticals Products and Services
11.22.5 Cerulean Pharma SWOT Analysis
11.22.6 Cerulean Pharma Recent Developments
11.23 Navidea Biopharmaceuticals
11.23.1 Navidea Biopharmaceuticals Corporation Information
11.23.2 Navidea Biopharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.23.4 Navidea Biopharmaceuticals Nanopharmaceuticals Products and Services
11.23.5 Navidea Biopharmaceuticals SWOT Analysis
11.23.6 Navidea Biopharmaceuticals Recent Developments
11.24 Lummy
11.24.1 Lummy Corporation Information
11.24.2 Lummy Business Overview and Total Revenue (2019 VS 2018)
11.24.3 Lummy Nanopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.24.4 Lummy Nanopharmaceuticals Products and Services
11.24.5 Lummy SWOT Analysis
11.24.6 Lummy Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Nanopharmaceuticals Sales Channels
12.2.2 Nanopharmaceuticals Distributors
12.3 Nanopharmaceuticals Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Nanopharmaceuticals Sales Forecast (2021-2026)
13.1.1 Global Nanopharmaceuticals Sales Forecast by Regions (2021-2026)
13.1.2 Global Nanopharmaceuticals Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Nanopharmaceuticals Sales Forecast (2021-2026)
13.2.2 North America Nanopharmaceuticals Revenue Forecast (2021-2026)
13.2.3 North America Nanopharmaceuticals Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Nanopharmaceuticals Sales Forecast (2021-2026)
13.3.2 Europe Nanopharmaceuticals Revenue Forecast (2021-2026)
13.3.3 Europe Nanopharmaceuticals Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Nanopharmaceuticals Sales Forecast (2021-2026)
13.4.2 Asia Pacific Nanopharmaceuticals Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Nanopharmaceuticals Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Nanopharmaceuticals Sales Forecast (2021-2026)
13.5.2 Latin America Nanopharmaceuticals Revenue Forecast (2021-2026)
13.5.3 Latin America Nanopharmaceuticals Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Nanopharmaceuticals Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Nanopharmaceuticals Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Nanopharmaceuticals Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Nanopharmaceuticals Key Market Segments
Table 2. Ranking of Global Top Nanopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nanopharmaceuticals Market Size Growth Rate by Type 2021-2026 (K MT) & (Million US$)
Table 4. Major Manufacturers of Liposomes
Table 5. Major Manufacturers of Polymeric Micelles
Table 6. Major Manufacturers of Solid Lipid Nanoparticles
Table 7. Major Manufacturers of Microemulsion and Nnanoemulsion
Table 8. Major Manufacturers of Nanosuspension
Table 9. Global Nanopharmaceuticals Market Share by Application 2019-2025 (K MT)
Table 10. Global Nanopharmaceuticals Market Size by Regions 2015-2020 (K MT) & (Million US$)
Table 11. Global Nanopharmaceuticals Sales by Regions 2015-2020 (K MT)
Table 12. Global Nanopharmaceuticals Sales Market Share by Regions 2015-2020
Table 13. Global Nanopharmaceuticals Revenue by Regions 2015-2020 (Million US$)
Table 14. Global Nanopharmaceuticals Revenue Market Share by Regions 2015-2020
Table 15. Top Nanopharmaceuticals Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 16. Market Top Trends
Table 17. Nanopharmaceuticals Key Drivers: Impact Analysis (2021-2026)
Table 18. Nanopharmaceuticals Key Challenges
Table 19. Main Points Interviewed from Key Nanopharmaceuticals Players: Views for Future
Table 20. Global Nanopharmaceuticals Sales by Manufacturers (2015-2020) (K MT)
Table 21. Global Nanopharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 22. Nanopharmaceuticals Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Nanopharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 24. Global Nanopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanopharmaceuticals as of 2019)
Table 26. Key Manufacturers Nanopharmaceuticals Average Selling Price (ASP) (2015-2020) (USD/MT)
Table 27. Key Manufacturers Nanopharmaceuticals Plants/Factories Distribution
Table 28. Key Manufacturers Nanopharmaceuticals Area Served
Table 29. Date of Key Manufacturers Enter into Nanopharmaceuticals Market
Table 30. Key Manufacturers Nanopharmaceuticals Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Liposomes Sales and Revenue (2015-2020) (K MT) & (Million US$)
Table 33. Global Polymeric Micelles Sales and Revenue (2015-2020) (K MT) & (Million US$)
Table 34. Global Solid Lipid Nanoparticles Sales ana Revenue (2015-2020) (K MT) & (Million US$)
Table 35. Global Microemulsion and Nnanoemulsion Sales ana Revenue (2015-2020) (K MT) & (Million US$)
Table 36. Global Nanosuspension Sales and Revenue (2015-2020) (K MT) & (Million US$)
Table 37. Global Nanopharmaceuticals Sales (K MT) by Type (2015-2020)
Table 38. Global Nanopharmaceuticals Sales Share by Type (2015-2020)
Table 39. Global Nanopharmaceuticals Revenue (US$ Million) Market Share by Type (2015-2020)
Table 40. Global Nanopharmaceuticals Price (K MT) by Type (2015-2020)
Table 41. Global Nanopharmaceuticals Sales (K MT) by Type (2021-2026)
Table 42. Global Nanopharmaceuticals Sales Share by Type (2021-2026)
Table 43. Global Nanopharmaceuticals Revenue (US$ Million) Market Share by Type (2021-2026)
Table 44. Global Nanopharmaceuticals Revenue Share by Type (2021-2026)
Table 45. Global Nanopharmaceuticals Price (K MT) by Type (2021-2026)
Table 46. Global Nanopharmaceuticals Sales (K MT) by Application (2015-2020)
Table 47. Global Nanopharmaceuticals Sales Share by Application (2015-2020)
Table 48. Global Nanopharmaceuticals Revenue (US$ Million) Market Share by Application (2015-2020)
Table 49. Global Nanopharmaceuticals Price by Application 2015-2020 (USD/MT)
Table 50. Global Nanopharmaceuticals Sales by Application (2015-2020) (K MT)
Table 51. Global Nanopharmaceuticals Sales Share by Application (2015-2020)
Table 52. Global Nanopharmaceuticals Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Global Nanopharmaceuticals Revenue Share by Application (2021-2026)
Table 54. Global Nanopharmaceuticals Price (K MT) by Application (2021-2026)
Table 55. North America Nanopharmaceuticals Sales by Company (2015-2020) (K MT)
Table 56. North America Nanopharmaceuticals Sales Market Share by Company (2015-2020)
Table 57. North America Nanopharmaceuticals Sales by Type (2015-2020) (K MT)
Table 58. North America Nanopharmaceuticals Sales Market Share by Type (2015-2020)
Table 59. North America Nanopharmaceuticals Sales by Application (2015-2020) (K MT)
Table 60. North America Nanopharmaceuticals Sales Market Share by Application (2015-2020)
Table 61. North America Nanopharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 62. North America Nanopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 63. North America Nanopharmaceuticals Revenue by Countries (2015-2020) (Million US$)
Table 64. North America Nanopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 65. Europe Nanopharmaceuticals Sales by Company (2015-2020) (K MT)
Table 66. Europe Nanopharmaceuticals Sales Market Share by Company (2015-2020)
Table 67. Europe Nanopharmaceuticals Sales by Type (2015-2020) (K MT)
Table 68. Europe Nanopharmaceuticals Sales Market Share by Type (2015-2020)
Table 69. Europe Nanopharmaceuticals Sales by Application (2015-2020) (K MT)
Table 70. Europe Nanopharmaceuticals Sales Market Share by Application (2015-2020)
Table 71. Europe Nanopharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 72. Europe Nanopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 73. Europe Nanopharmaceuticals Revenue by Countries (2015-2020) (Million US$)
Table 74. Europe Nanopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 75. Asia Pacific Nanopharmaceuticals Sales by Regions (2015-2020) (K MT)
Table 76. Asia Pacific Nanopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Nanopharmaceuticals Sales by Type (2015-2020) (K MT)
Table 78. Asia Pacific Nanopharmaceuticals Sales Market Share by Type (2015-2020)
Table 79. Asia Pacific Nanopharmaceuticals Sales by Application (2015-2020) (K MT)
Table 80. Asia Pacific Nanopharmaceuticals Sales Market Share by Application (2015-2020)
Table 81. Asia Pacific Nanopharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 82. Asia Pacific Nanopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 83. Asia Pacific Nanopharmaceuticals Revenue by Regions (2015-2020) (Million US$)
Table 84. Asia Pacific Nanopharmaceuticals Revenue Market Share by Regions (2015-2020)
Table 85. Latin America Nanopharmaceuticals Sales by Company (2015-2020) (K MT)
Table 86. Latin America Nanopharmaceuticals Sales Market Share by Company (2015-2020)
Table 87. Latin America Nanopharmaceuticals Sales by Type (2015-2020) (K MT)
Table 88. Latin America Nanopharmaceuticals Sales Market Share by Type (2015-2020)
Table 89. Latin America Nanopharmaceuticals Sales by Application (2015-2020) (K MT)
Table 90. Latin America Nanopharmaceuticals Sales Market Share by Application (2015-2020)
Table 91. Latin America Nanopharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 92. Latin America Nanopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 93. Latin America Nanopharmaceuticals Revenue by Countries (2015-2020) (Million US$)
Table 94. Latin America Nanopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Nanopharmaceuticals Sales by Type (2015-2020) (K MT)
Table 96. Middle East and Africa Nanopharmaceuticals Sales Market Share by Type (2015-2020)
Table 97. Middle East and Africa Nanopharmaceuticals Sales by Application (2015-2020) (K MT)
Table 98. Middle East and Africa Nanopharmaceuticals Sales Market Share by Application (2015-2020)
Table 99. Middle East and Africa Nanopharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 100. Middle East and Africa Nanopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 101. Middle East and Africa Nanopharmaceuticals Revenue by Countries (2015-2020) (Million US$)
Table 102. Middle East and Africa Nanopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 103. Merck Company Details
Table 104. Merck Description and Business Overview
Table 105. Merck Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Merck Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 107. Merck Nanopharmaceuticals Sales Market Share in Global Market
Table 108. Merck Recent Development
Table 109. Pfizer Company Details
Table 110. Pfizer Description and Business Overview
Table 111. Pfizer Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Pfizer Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 113. Pfizer Nanopharmaceuticals Sales Market Share in Global Market
Table 114. Pfizer Recent Development
Table 115. Novartis Company Details
Table 116. Novartis Description and Business Overview
Table 117. Novartis Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Novartis Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 119. Novartis Nanopharmaceuticals Sales Market Share in Global Market
Table 120. Novartis Recent Development
Table 121. Abbott Company Details
Table 122. Abbott Description and Business Overview
Table 123. Abbott Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Abbott Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 125. Abbott Nanopharmaceuticals Sales Market Share in Global Market
Table 126. Abbott Recent Development
Table 127. GlaxoSmithKline Company Details
Table 128. GlaxoSmithKline Description and Business Overview
Table 129. GlaxoSmithKline Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 130. GlaxoSmithKline Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 131. GlaxoSmithKline Nanopharmaceuticals Sales Market Share in Global Market
Table 132. GlaxoSmithKline Recent Development
Table 133. Roche Company Details
Table 134. Roche Description and Business Overview
Table 135. Roche Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 136. Roche Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 137. Roche Nanopharmaceuticals Sales Market Share in Global Market
Table 138. Roche Recent Development
Table 139. Sanofi Company Details
Table 140. Sanofi Description and Business Overview
Table 141. Sanofi Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Sanofi Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 143. Sanofi Nanopharmaceuticals Sales Market Share in Global Market
Table 144. Sanofi Recent Development
Table 145. Eli Lilly Company Details
Table 146. Eli Lilly Description and Business Overview
Table 147. Eli Lilly Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Eli Lilly Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 149. Eli Lilly Nanopharmaceuticals Sales Market Share in Global Market
Table 150. Eli Lilly Recent Development
Table 151. Astrazeneca Company Details
Table 152. Astrazeneca Description and Business Overview
Table 153. Astrazeneca Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 154. Astrazeneca Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 155. Astrazeneca Nanopharmaceuticals Sales Market Share in Global Market
Table 156. Astrazeneca Recent Development
Table 157. Johnson & Johnson Company Details
Table 158. Johnson & Johnson Description and Business Overview
Table 159. Johnson & Johnson Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 160. Johnson & Johnson Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 161. Johnson & Johnson Nanopharmaceuticals Sales Market Share in Global Market
Table 162. Johnson & Johnson Recent Development
Table 163. Celgene Company Details
Table 164. Celgene Description and Business Overview
Table 165. Celgene Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 166. Celgene Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 167. Celgene Nanopharmaceuticals Sales Market Share in Global Market
Table 168. Celgene Recent Development
Table 169. Novavax Company Details
Table 170. Novavax Description and Business Overview
Table 171. Novavax Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 172. Novavax Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 173. Novavax Nanopharmaceuticals Sales Market Share in Global Market
Table 174. Novavax Recent Development
Table 175. Stryker Company Details
Table 176. Stryker Description and Business Overview
Table 177. Stryker Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 178. Stryker Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 179. Stryker Nanopharmaceuticals Sales Market Share in Global Market
Table 180. Stryker Recent Development
Table 181. Gilead Sciences Company Details
Table 182. Gilead Sciences Description and Business Overview
Table 183. Gilead Sciences Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 184. Gilead Sciences Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 185. Gilead Sciences Nanopharmaceuticals Sales Market Share in Global Market
Table 186. Gilead Sciences Recent Development
Table 187. OSI Pharmaceuticals Company Details
Table 188. OSI Pharmaceuticals Description and Business Overview
Table 189. OSI Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 190. OSI Pharmaceuticals Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 191. OSI Pharmaceuticals Nanopharmaceuticals Sales Market Share in Global Market
Table 192. OSI Pharmaceuticals Recent Development
Table 193. Kadmon Pharmaceuticals Company Details
Table 194. Kadmon Pharmaceuticals Description and Business Overview
Table 195. Kadmon Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 196. Kadmon Pharmaceuticals Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 197. Kadmon Pharmaceuticals Nanopharmaceuticals Sales Market Share in Global Market
Table 198. Kadmon Pharmaceuticals Recent Development
Table 199. Samyang Biopharm Company Details
Table 200. Samyang Biopharm Description and Business Overview
Table 201. Samyang Biopharm Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 202. Samyang Biopharm Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 203. Samyang Biopharm Nanopharmaceuticals Sales Market Share in Global Market
Table 204. Samyang Biopharm Recent Development
Table 205. Mitsubishi Pharma Company Details
Table 206. Mitsubishi Pharma Description and Business Overview
Table 207. Mitsubishi Pharma Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 208. Mitsubishi Pharma Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 209. Mitsubishi Pharma Nanopharmaceuticals Sales Market Share in Global Market
Table 210. Mitsubishi Pharma Recent Development
Table 211. Kaken Pharmaceutical Company Details
Table 212. Kaken Pharmaceutical Description and Business Overview
Table 213. Kaken Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 214. Kaken Pharmaceutical Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 215. Kaken Pharmaceutical Nanopharmaceuticals Sales Market Share in Global Market
Table 216. Kaken Pharmaceutical Recent Development
Table 217. Selecta Biosciences Company Details
Table 218. Selecta Biosciences Description and Business Overview
Table 219. Selecta Biosciences Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 220. Selecta Biosciences Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 221. Selecta Biosciences Nanopharmaceuticals Sales Market Share in Global Market
Table 222. Selecta Biosciences Recent Development
Table 223. Par Pharmaceutical Company Details
Table 224. Par Pharmaceutical Description and Business Overview
Table 225. Par Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 226. Par Pharmaceutical Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 227. Par Pharmaceutical Nanopharmaceuticals Sales Market Share in Global Market
Table 228. Par Pharmaceutical Recent Development
Table 229. Cerulean Pharma Company Details
Table 230. Cerulean Pharma Description and Business Overview
Table 231. Cerulean Pharma Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 232. Cerulean Pharma Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 233. Cerulean Pharma Nanopharmaceuticals Sales Market Share in Global Market
Table 234. Cerulean Pharma Recent Development
Table 235. Navidea Biopharmaceuticals Company Details
Table 236. Navidea Biopharmaceuticals Description and Business Overview
Table 237. Navidea Biopharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 238. Navidea Biopharmaceuticals Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 239. Navidea Biopharmaceuticals Nanopharmaceuticals Sales Market Share in Global Market
Table 240. Navidea Biopharmaceuticals Recent Development
Table 241. Lummy Company Details
Table 242. Lummy Description and Business Overview
Table 243. Lummy Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 244. Lummy Nanopharmaceuticals Sales Growth Rate (2015-2020)
Table 245. Lummy Nanopharmaceuticals Sales Market Share in Global Market
Table 246. Lummy Recent Development
Table 247. Nanopharmaceuticals Distributors List
Table 248. Nanopharmaceuticals Customers List
Table 249. Global Nanopharmaceuticals Sales Forecast 2021-2026 (K MT) & (Million US$)
Table 250. Global Nanopharmaceuticals Sales Forecast by Type 2021-2026 (K MT)
Table 251. Global Nanopharmaceuticals Sales Forecast by Application 2021-2026 (K MT)
Table 252. Global Nanopharmaceuticals Sales Forecast by Regions 2021-2026 (K MT)
Table 253. Global Nanopharmaceuticals Revenue Forecast by Regions 2021-2026 (Million US$)
Table 254. North America Nanopharmaceuticals Sales Forecast by Countries 2021-2026 (K MT)
Table 255. North America Nanopharmaceuticals Revenue Forecast by Countries 2021-2026
Table 256. Europe Nanopharmaceuticals Sales Forecast by Countries 2021-2026 (K MT)
Table 257. Europe Nanopharmaceuticals Revenue Market Share Forecast by Countries 2021-2026
Table 258. Asia Pacific Nanopharmaceuticals Sales Forecast by Regions 2021-2026 (K MT)
Table 259. Asia Pacific Nanopharmaceuticals Revenue Forecast by Regions 2021-2026 (Million US$)
Table 260. Latin America Nanopharmaceuticals Sales Forecast by Countries 2021-2026 (K MT)
Table 261. Latin America Nanopharmaceuticals Revenue Forecast by Countries 2021-2026 (Million US$)
Table 262. Middle East and Africa Nanopharmaceuticals Sales Forecast by Regions 2021-2026 (K MT)
Table 263. Middle East and Africa Nanopharmaceuticals Revenue Forecast by Regions 2021-2026 (Million US$)
Table 264. Research Programs/Design for This Report
Table 265. Key Data Information from Secondary Sources
Table 266. Key Data Information from Primary Sources
List of Figures
Figure 1. Nanopharmaceuticals Product Picture
Figure 2. Global Nanopharmaceuticals Sales Market Shar by Type 2015-2026
Figure 3. Liposomes Figures
Figure 4. Polymeric Micelles Figures
Figure 5. Solid Lipid Nanoparticles Figures
Figure 6. Microemulsion and Nnanoemulsion Figures
Figure 7. Nanosuspension Figures
Figure 8. Global Nanopharmaceuticals Sales Market Share by Application in 2019 & 2026
Figure 9. Cancer and Tumor Use Case
Figure 10. Autoimmune Disorders Use Case
Figure 11. Inflammation Use Case
Figure 12. Others Use Case
Figure 13. Nanopharmaceuticals Report Years Considered
Figure 14. Global Nanopharmaceuticals Market Size 2015-2026 (Million US$)
Figure 15. Global Nanopharmaceuticals Sales 2015-2020 (K MT)
Figure 16. Global Nanopharmaceuticals Market Size Market Share by Regions 2015-2020
Figure 17. Global Nanopharmaceuticals Sales Market Share by Regions in 2019
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Nanopharmaceuticals Sales Share by Manufacturers in 2019
Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Nanopharmaceuticals Sales in 2019
Figure 21. Nanopharmaceuticals Value Share by Manufacturers in 2019
Figure 22. Nanopharmaceuticals Revenue Share by Manufacturers In 2019
Figure 23. Nanopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Nanopharmaceuticals Revenue Share by Type (2015-2020)
Figure 25. Global Nanopharmaceuticals Revenue Growth Rate by Type in 2015 & 2019
Figure 26. Global Nanopharmaceuticals Market Share by Price Range (2015-2020)
Figure 27. Global Nanopharmaceuticals Revenue Share by Application (2015-2020)
Figure 28. Global Nanopharmaceuticals Revenue Growth Rate by Application in 2015 & 2019
Figure 29. North America Nanopharmaceuticals Revenue Growth Rate 2015-2020 (Million US$)
Figure 30. U.S. Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 31. Canada Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 32. Europe Nanopharmaceuticals Revenue Growth Rate 2015-2020 (Million US$)
Figure 33. Germany Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 34. France Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.K. Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 36. Italy Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 37. Russia Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 38. Asia Pacific Nanopharmaceuticals Revenue Growth Rate 2015-2020 (Million US$)
Figure 39. China Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 40. Japan Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 41. South Korea Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 42. India Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 43. Australia Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 44. Taiwan Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 45. Indonesia Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 46. Thailand Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 47. Malaysia Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 48. Philippines Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 49. Vietnam Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 50. Latin America Nanopharmaceuticals Revenue Growth Rate 2015-2020 (Million US$)
Figure 51. Mexico Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 52. Brazil Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 53. Argentina Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 54. Middle East and Africa Nanopharmaceuticals Revenue Growth Rate 2015-2020 (Million US$)
Figure 55. Turkey Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 56. Saudi Arabia Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 57. U.A.E Nanopharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 58. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Novavax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Stryker Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. OSI Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 73. Kadmon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 74. Samyang Biopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 75. Mitsubishi Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 76. Kaken Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Selecta Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Par Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Cerulean Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Navidea Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Lummy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Nanopharmaceuticals Value Chain
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. North America Nanopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 86. North America Nanopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 87. Europe Nanopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 88. Europe Nanopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 89. Asia Pacific Nanopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 90. Asia Pacific Nanopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 91. Latin America Nanopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 92. Latin America Nanopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 93. Middle East and Africa Nanopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 94. Middle East and Africa Nanopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed


【掲載企業】

Merck、Pfizer、Novartis、Abbott、GlaxoSmithKline、Roche、Sanofi、Eli Lilly、Astrazeneca、Johnson & Johnson、Celgene、Novavax、Stryker、Gilead Sciences、OSI Pharmaceuticals、Kadmon Pharmaceuticals、Samyang Biopharm、Mitsubishi Pharma、Kaken Pharmaceutical、Selecta Biosciences、Par Pharmaceutical、Cerulean Pharma、Navidea Biopharmaceuticals、Lummy

★調査レポート[世界のナノ医薬品市場:成長動向・競争分析2020-2026] (コード:QYR20AP01564)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のナノ医薬品市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆